Comparison timestamp: 2025-05-01 07:57:15 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/flu/professionals/diagnosis/table-testing-methods.htm
Live cdc.gov URL ↗: https://www.cdc.gov/flu/professionals/diagnosis/table-testing-methods.htm
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/flu/professionals/diagnosis/table-testing-methods.htm
Live cdc.gov URL ↗: https://www.cdc.gov/flu/professionals/diagnosis/table-testing-methods.htm
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/flu/php/laboratories/table-testing-methods.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to searchAn official website of the United States governmentHere's how you knowOfficial websites use .govA .gov website belongs to an official government organization in the United States.Secure .gov websites use HTTPSA lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.Influenza (Flu)Explore TopicsSearchSearch Clear InputSearchFor Everyone* About* Signs and Symptoms* Causes and Spread* Flu Complications and People at Higher Risk* Prevention* Vaccine Basics* Diagnosis* Flu Treatment* View allHealth Care Providers* Clinical Guidance* Clinical Signs and Symptoms of Influenza* Guidance for Influenza Vaccination* Vaccine Product Information* Clinical Testing and Diagnosis* About Influenza Antiviral Medications* Infection Control Guidance* Laboratory Testing* View allPublic Health* How CDC Classifies Flu Severity each Season in the United States* Information for Laboratories* Understanding Influenza Viruses* WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza* Viral Genomic Sequencing Infrastructure* View allRelated Topics:Avian Flu | Swine Flu | Flu in Animals | Flu Vaccines Work | Flu Forecasting | Flu BurdenView Allsearch close searchsearchInfluenza (Flu) Menu CloseInfluenza (Flu) MenusearchFor Everyone* About* Signs and Symptoms* Causes and Spread* Flu Complications and People at Higher Risk* Prevention* Vaccine Basics* Diagnosis* Flu Treatment* View All HomeHealth Care Providers* Clinical Guidance* Clinical Signs and Symptoms of Influenza* Guidance for Influenza Vaccination* Vaccine Product Information* Clinical Testing and Diagnosis* About Influenza Antiviral Medications* Infection Control Guidance* Laboratory Testing* View All HomePublic Health* How CDC Classifies Flu Severity each Season in the United States* Information for Laboratories* Understanding Influenza Viruses* WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza* Viral Genomic Sequencing Infrastructure* View AllRelated Topics* Avian Flu* Swine Flu* Flu in Animals* Flu Vaccines Work* Flu Forecasting* Flu BurdenView All Influenza (Flu)How CDC Classifies Flu Severity each Season in the United States Information for Laboratories Understanding Influenza Viruses WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza Viral Genomic Sequencing Infrastructure View AllAugust 12, 2024EspañolInfluenza Virus Testing MethodsPurposeTable depicting Influenza virus testing methods.Table: Influenza Virus Testing MethodsTable 1: Influenza Virus Testing MethodsMethod1 Types Detected Acceptable Specimens2 Test Time CLIA Waived3Rapid Influenza Diagnostic Tests (antigen detection)4 A and B NP swab, aspirate or wash, nasal swab, aspirate or wash, throat swab <15 min. Yes/NoRapid Molecular Assay [influenza viral RNA or nucleic acid detection] A and B NP swab, nasal swab 15-30 minutes5 Yes/No5Immunofluorescence, Direct (DFA) or Indirect (IFA) Florescent Antibody Staining [antigen detection] A and B NP swab or wash, bronchial wash, nasal or endotracheal aspirate 1-4 hours NoRT-PCR6 (singleplex and multiplex; real-time and other RNA-based) and other molecular assays [influenza viral RNA or nucleic acid detection] A and B NP swab, throat swab, NP or bronchial wash, nasal or endotracheal aspirate, sputum Varies (1 to 8 hours, varies by the assay) NoRapid cell culture (shell vials; cell mixtures; yields live virus) A and B NP swab, throat swab, NP or bronchial wash, nasal or endotracheal aspirate, sputum; (specimens placed in VTM) 1-3 days NoViral tissue cell culture (conventional; yields live virus) A and B NP swab, throat swab, NP or bronchial wash, nasal or endotracheal aspirate, sputum (specimens placed in VTM8) 3-10 days NoAbbreviationsFDA = U.S. Food and Drug AdministrationA = aspirateB = bronchialBAL = broncheoalveolar lavageN = nasalNP = nasopharyngealS = swabT = throatTR = trachealUTM = universal transport mediaVTM = viral transport mediaW = washAugust 12, 2024Sources Print ShareFacebook LinkedIn Twitter SyndicateContent Source:National Center for Immunization and Respiratory Diseases (NCIRD)References1. Serologic (antibody detection) testing is not recommended for routine patient diagnosis and cannot inform clinical management. A single acute serum specimen for seasonal influenza serology is uninterpretable and should not be collected. Serological testing for detection of antibodies to seasonal influenza viruses is useful for research studies and requires collection of appropriately timed acute and convalescent serum specimens and testing of paired sera at specialized research or public health laboratories.2. Approved clinical specimens vary by influenza test. Consult the manufacturer's package insert for the approved clinical specimens for each test. Ref: Leland, et al. 2007, Clin Micro Rev 20: 49-78. Approved respiratory specimens vary among FDA cleared influenza assays.3. Clinical Laboratory Improvement Amendments (CLIA) of 1988. http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html4. Chromatographic- and/or fluorescence-based lateral flow and membrane-based immunoassays. Some approved rapid influenza diagnostic assays utilize an analyzer reader device.5. Rapid molecular assays can provide results in approximately 15-30 minutes.6. Reverse transcription polymerase chain reaction, including FDA-approved test systems, laboratory testing using analyte specific reagents, or lab-developed reagents. Some approved molecular assays can produce results in approximately 60-80 minutes.Sources* Conjunctival swabs are currently approved under FDA enforcement discretion for testing with the CDC Influenza A/H5 subtyping assay.Influenza (Flu)Influenza (flu) is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs.View AllFor Everyone* About* Signs and Symptoms* Causes and Spread* Flu Complications and People at Higher Risk* Prevention* Vaccine Basics* Diagnosis* Flu Treatment* View allHealth Care Providers* Clinical Guidance* Clinical Signs and Symptoms of Influenza* Guidance for Influenza Vaccination* View AllPublic Health* How CDC Classifies Flu Severity each Season in the United States* Information for Laboratories* Understanding Influenza Viruses* View AllSign up for Email UpdatesContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & JobsPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsContact UsContact Us* Call 800-232-4636* Contact CDCAbout CDC* Pressroom* Organization* Budget & Funding* Careers & Jobs* About CDCPolicies* Accessibility* External Links* Privacy* Web Policies* FOIA* OIG* No Fear Act* Nondiscrimination* Vulnerability Disclosure PolicyLanguagesLanguages* EspañolLanguage Assistance* Español* 繁體中文* Tiếng Việt* 한국어* Tagalog* Русский* العربية* Kreyòl Ayisyen* Français* Polski* Português* Italiano* Deutsch* 日本語* فارسی* EnglishArchive* CDC Archive* Public Health PublicationsHHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.